Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Galapagos N.V. | 0.080% | -3.297% | -7.563% | -29.185% | -28.726% | -58.062% | - |
Affimed N.V. | 0.090% | - | - | - | - | - | - |
Jazz Pharmaceuticals plc | 0.100% | 2.843% | 0.914% | -16.147% | -5.961% | -27.953% | -12.583% |
Corvus Pharmaceuticals Inc | 0.110% | 1.848% | 33.476% | 4.693% | 23.289% | -9.904% | -49.920% |
Eastpharma GDR Reg. S1 | 0.140% | - | - | - | - | - | - |
Viking Therapeutics Inc | 0.150% | -7.654% | 3.903% | 223.277% | 283.643% | 1269.259% | - |
GenKyoTex S.A. | 0.160% | - | - | - | - | - | - |
Daiichi Sankyo Co Ltd | 0.190% | -2.921% | 15.514% | 3.267% | 30.263% | 58.117% | - |
Novartis AG ADR | 0.210% | 4.405% | 7.727% | -0.211% | 3.947% | 29.863% | 32.978% |
Fagron N.V. | 0.210% | 3.077% | 7.078% | 9.197% | 12.201% | -1.159% | - |
Solon Eiendom ASA | 0.230% | - | - | - | - | - | - |
Albireo Pharma Inc. | 0.290% | - | - | - | - | - | - |
Transgene S.A. | 0.300% | 8.007% | -3.504% | -25.311% | -1.343% | -45.930% | -57.492% |
Teva Pharmaceutical Industries Ltd ADR | 0.320% | 19.466% | 24.701% | 110.916% | 67.918% | 83.255% | 42.922% |
Haemato AG | 0.330% | - | - | - | - | - | - |
Heidelberg Pharma AG | 0.340% | -2.295% | -2.295% | -24.173% | -19.022% | -50.580% | 4.561% |
Amgen Inc. | 0.350% | 2.786% | 13.788% | 33.124% | 9.728% | 36.785% | 91.015% |
Sarepta Therapeutics | 0.370% | -2.592% | 5.712% | 11.146% | 38.054% | 108.021% | 22.174% |
Genmab A/S | 0.370% | 0.707% | -1.922% | -29.740% | -6.239% | -9.743% | 84.076% |
Kiadis Pharma Bv | 0.370% | - | - | - | - | - | - |
Charles River Labs Intl | 0.380% | -2.167% | -6.437% | 20.431% | -0.376% | -19.621% | - |
Perrigo Co. plc | 0.390% | -8.113% | 0.070% | -14.062% | -1.688% | -23.280% | -35.430% |
Zoetis Inc. A | 0.420% | 1.025% | 10.397% | -8.002% | -12.452% | 10.790% | 74.077% |
Bavarian Nordic A/S | 0.450% | 3.903% | 10.693% | -20.934% | -7.489% | -36.023% | - |
Vericel Corp. | 0.450% | 2.740% | 0.000% | 49.007% | 38.889% | 18.421% | 208.261% |